Contribution: Innovation for Defence Excellence and and Security
Diagnostics BioChem Canada Inc.
$1,014,000.00
SARS-CoV-2 ELISA Kits
FY 2020-21 · 2020-06-18
Summary
Develop immunoassay kits that can measure all three classes of SARS-CoV-2 antibodies simultaneously or individually.
Department
Program
Innovation for Defence Excellence and and Security
Recipient
Location
London, Ontario, Canada
Recipient Type
For-profit organization
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2021-09-30
Agreement Start Date
2020-06-18
Agreement Title
SARS-CoV-2 ELISA Kits
Agreement Type
Contribution
Agreement Value
$1,014,000.00
Amendment Number
0
Coverage
Canada
Description
Develop immunoassay kits that can measure all three classes of SARS-CoV-2 antibodies simultaneously or individually.
Description (French)
Développer des trousses d'immunoessais qui peuvent mesurer les trois classes d'anticorps SARS-CoV-2 simultanément ou individuellement.
Expected Results
The primary objective is to develop an immunoassay that can be used in combination with RT-PCR for COVID-19 diagnosis, can be use to determine which individuals have been infected and have recovered, and can be used with a dry blood spot collection as part of a home test.
Expected Results (French)
L'objectif principal est de développer un immunoessai qui peut être utilisé en combinaison avec la RT-PCR pour le diagnostic de COVID-19, qui peut être utilisé pour déterminer quels individus ont été infectés et se sont rétablis, et qui peut être utilisé avec un prélèvement de sang sec dans le cadre d'un test à domicile.
Organization Code
dnd-mdn
Organization
National Defence | Défense nationale
Program Name
Innovation for Defence Excellence and and Security
Program Name (French)
Innovation pour la defense, l'exellence et la securite
Program Purpose
To encourage the creation of new ideas and formulate solutions to Canada’s current and future defence and security requirements
Recipient Business Number
123926966R001
Recipient City
London
Recipient Country
CA
Recipient Legal Name
Diagnostics BioChem Canada Inc.
Recipient Operating Name
Diagnostics BioChem Canada Inc.
Recipient Postal Code
N6M 1A1
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
032-2020-2021-Q1-00023
